<DOC>
	<DOCNO>NCT00982826</DOCNO>
	<brief_summary>To assess safety , tolerability pharmacokinetics ABT-072 tablet formulation administer single dose administer multiple dos 7 day . The effect food safety , tolerability pharmacokinetics ABT-072 tablet also evaluate .</brief_summary>
	<brief_title>Single Multiple Dose Evaluation ABT-072 Evaluate Effect Food Pharmacokinetics ABT-072</brief_title>
	<detailed_description>The study consist two substudies . Substudy 1 two-period , single ascend dose ( SAD ) multiple ascend dose ( MAD ) blind , randomize , placebo-controlled , non-fasting study . Designated group participate Period 1 ( SAD ) also participate Period 2 ( MAD ) . Substudy 2 open-label , randomize two-period , crossover study examine effect food pharmacokinetics ABT 072 .</detailed_description>
	<mesh_term>Hepatitis C</mesh_term>
	<criteria>Overall healthy subject , nonchildbearing female include . Use medication ( prescription overthecounter ) , vitamin , herbal supplement within 2week period prior first dose study drug administration within 10 halflives respective medication , whichever longer . Pregnant breastfeed female . Positive test result hepatitis A virus immunoglobulin M ( HAVIgM ) , hepatitis B surface antigen ( HBsAg ) , hepatitis C virus antibody ( HCV Ab ) , HIV antibody ( HIV Ab ) . Positive screen drug abuse , alcohol , cotinine . Clinically significant cardiovascular , respiratory ( except mild asthma ) , renal , gastrointestinal , hematologic , neurologic , thyroid , uncontrolled medical illness psychiatric disorder . Use tobacco nicotinecontaining product within 6month period precede study drug administration .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>Phase 1</keyword>
	<keyword>Single Multiple Ascending Dose</keyword>
	<keyword>Food Effect</keyword>
</DOC>